Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

MicroRNA Signatures of Colonic Polyps on Screening and Histology.

Tsikitis VL, Potter A, Mori M, Buckmeier JA, Preece CR, Harrington CA, Bartley AN, Bhattacharyya AK, Hamilton SR, Lance MP, Thompson PA.

Cancer Prev Res (Phila). 2016 Dec;9(12):942-949. Epub 2016 Sep 22.

2.

Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez ME, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw152. doi: 10.1093/jnci/djw152. Print 2016 Dec.

3.

Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow SH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez EM, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw151. doi: 10.1093/jnci/djw151. Print 2016 Dec.

4.

Differential expression of microRNA-320a, -145, and -192 along the continuum of normal mucosa to high-grade dysplastic adenomas of the colorectum.

Tsikitis VL, White I, Mori M, Potter A, Bhattcharyya A, Hamilton SR, Buckmeier J, Lance P, Thompson P.

Am J Surg. 2014 May;207(5):717-22; discussion 722. doi: 10.1016/j.amjsurg.2013.12.023. Epub 2014 Mar 12.

5.

Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia.

Bartley AN, Parikh N, Hsu CH, Roe DJ, Buckmeier JA, Corley L, Phipps RA, Gallick G, Lance P, Thompson PA, Hamilton SR.

Cancer Prev Res (Phila). 2013 Nov;6(11):1162-70. doi: 10.1158/1940-6207.CAPR-13-0113. Epub 2013 Sep 5.

6.

Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention.

Thompson P, Roe DJ, Fales L, Buckmeier J, Wang F, Hamilton SR, Bhattacharyya A, Green S, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Martinez ME, Jacobs E, Ashbeck EL, Alberts DS, Lance P.

Cancer Prev Res (Phila). 2012 Dec;5(12):1381-93. doi: 10.1158/1940-6207.CAPR-12-0204. Epub 2012 Oct 11.

7.

Loss of heterozygosity at the glutathione peroxidase 1 locus is not an early event in colon carcinogenesis.

Goldberg M, Alberts DS, Buckmeier JA, Prasad AR, Krouse RS, Diamond AM.

Genes Cancer. 2011 Sep;2(9):910-3. doi: 10.1177/1947601911431840.

8.

Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma.

Jacobs E, Martinez ME, Buckmeier J, Lance P, May M, Jurutka P.

J Carcinog. 2011 Feb 12;10:3. doi: 10.4103/1477-3163.76723.

9.

Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps.

Bartley AN, Thompson PA, Buckmeier JA, Kepler CY, Hsu CH, Snyder MS, Lance P, Bhattacharyya A, Hamilton SR.

Mod Pathol. 2010 Feb;23(2):169-76. doi: 10.1038/modpathol.2009.155. Epub 2009 Oct 23.

10.

Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.

Einspahr JG, Xu MJ, Warneke J, Saboda K, Ranger-Moore J, Bozzo P, Duckett L, Goldman R, Lin P, Buckmeier J, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1841-8. Epub 2006 Oct 4.

11.

MGMT promoter methylation and field defect in sporadic colorectal cancer.

Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP.

J Natl Cancer Inst. 2005 Sep 21;97(18):1330-8.

PMID:
16174854
12.

Disulfiram induces apoptosis in human melanoma cells: a redox-related process.

Cen D, Gonzalez RI, Buckmeier JA, Kahlon RS, Tohidian NB, Meyskens FL Jr.

Mol Cancer Ther. 2002 Jan;1(3):197-204.

13.

Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes.

Meyskens FL Jr, McNulty SE, Buckmeier JA, Tohidian NB, Spillane TJ, Kahlon RS, Gonzalez RI.

Free Radic Biol Med. 2001 Sep 15;31(6):799-808.

PMID:
11557318
14.

Correlation of chemopreventive efficacy data from the human epidermal cell assay with in vivo data.

Elmore E, Luc TT, Li HR, Buckmeier JA, Steele VE, Kelloff GJ, Redpath JL.

Anticancer Res. 2000 Jan-Feb;20(1A):27-32.

PMID:
10769631
15.

In vitro chemopreventive efficacy screening using human keratinocytes and the in vivo data correlation.

Elmore E, Sun C, Li HR, Wyatt GP, Buckmeier JA, Steele VE, Kelloff GJ, Redpath JL.

Anticancer Res. 1999 Mar-Apr;19(2A):909-18.

PMID:
10368633
16.

Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress.

Meyskens FL Jr, Buckmeier JA, McNulty SE, Tohidian NB.

Clin Cancer Res. 1999 May;5(5):1197-202.

17.

Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress.

Meyskens FL Jr, Chau HV, Tohidian N, Buckmeier J.

Pigment Cell Res. 1997 Jun;10(3):184-9.

18.

Variable expression of IL-1 beta has minimal effect on the radiation sensitivity of three human glioma cell lines.

Ross HJ, Antoniono RJ, Buckmeier JA, Redpath JL.

Int J Radiat Biol. 1994 Dec;66(6):785-91.

PMID:
7814977
19.

Protein kinase C beta expression in melanoma cells and melanocytes: differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetate.

Powell MB, Rosenberg RK, Graham MJ, Birch ML, Yamanishi DT, Buckmeier JA, Meyskens FL Jr.

J Cancer Res Clin Oncol. 1993;119(4):199-206.

20.

Comparison of calmodulin gene expression in human neonatal melanocytes and metastatic melanoma cell lines.

Hickie RA, Graham MJ, Buckmeier JA, Meyskens FL Jr.

J Invest Dermatol. 1992 Dec;99(6):764-73.

21.

Differences in basic fibroblast growth factor RNA and protein levels in human primary melanocytes and metastatic melanoma cells.

Yamanishi DT, Graham MJ, Florkiewicz RZ, Buckmeier JA, Meyskens FL Jr.

Cancer Res. 1992 Sep 15;52(18):5024-9.

22.

Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas.

Yamanishi DT, Buckmeier JA, Meyskens FL Jr.

J Invest Dermatol. 1991 Aug;97(2):349-53.

23.

The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas.

Yamanishi DT, Graham M, Buckmeier JA, Meyskens FL Jr.

Carcinogenesis. 1991 Jan;12(1):105-9.

24.

Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity.

Powell MB, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M, Ruddle NH, Steinman L.

Int Immunol. 1990;2(6):539-44.

PMID:
1707660
25.

Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival.

Meyskens FL Jr, Thomson SP, Buckmeier J.

Clin Exp Metastasis. 1989 Nov-Dec;7(6):627-32.

PMID:
2776367
26.

Tetrazolium staining by optical scanning overestimates colony size and number of colonies counted.

Bregman MD, Buckmeier J, Meyskens FL Jr.

Int J Cell Cloning. 1987 Nov;5(6):472-9.

PMID:
3429933
27.

Supplemental Content

Loading ...
Support Center